{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T11:05:29Z","timestamp":1767179129958,"version":"build-2238731810"},"update-to":[{"DOI":"10.1371\/journal.pntd.0010629","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T00:00:00Z","timestamp":1658707200000}}],"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Task Force for Global Health","award":["1491"],"award-info":[{"award-number":["1491"]}]},{"name":"El-Maghraby chair at the Wilmer Eye Institute"},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Serologic testing for chlamydial antibodies is one potential tool for trachoma monitoring. Understanding the dynamics of seroconversion and seroreversion in low endemic districts is critical for determining the value of using serology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methodology\/Principal findings<\/jats:title>\n                    <jats:p>\n                      We surveyed a random sample of 2536 children aged 1\u20139 years in Kongwa, Tanzania, over three years; 1719 (67.8%) participants had all three follow-ups. Surveys assessed trachomatous inflammation\u2014follicular (TF),\n                      <jats:italic>Chlamydia trachomatis<\/jats:italic>\n                      infection, and anti-pgp3 antibodies. Mass drug administration occurred immediately after the first and second follow-up surveys. The cohort was classified into trajectories of change in serostatus, and risk factors were evaluated for seroconversion and seroreversion. We found that 86.2% of seropositives remained seropositive throughout the study, whereas 12.1% seroreverted. Seroreverters were younger (Odds Ratio [OR] = 0.88 for every one-year increase in age, 95% CI = 0.79\u20130.99). 84.5% of seronegatives remained seronegative, and 13.0% seroconverted. Seroconverters were also younger (OR = 0.92, 95% CI = 0.87\u20130.98). Seroconversion and seroreversion were not explained by indeterminate values for the intensity of antibody response. Less than 1% of the cohort had unstable changes in serostatus, mostly explained by values in the indeterminate range. TF and infection in the cohort declined over time, while seropositivity increased from 31.5% to 36.4%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Conclusions\/Significance<\/jats:title>\n                    <jats:p>Antibody status is relatively stable over time. Both seroconversion and seroreversion occurred over the three years in this low endemic district, especially in younger children. Modeling seroreversion is important for accurate determination of seroconversion. The use of serology as a monitoring tool should target the younger aged children as they will most likely capture recent changes in serostatus.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pntd.0010629","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T13:42:55Z","timestamp":1657719775000},"page":"e0010629","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Risk of seroconversion and seroreversion of antibodies to Chlamydia trachomatis pgp3 in a longitudinal cohort of children in a low trachoma prevalence district in Tanzania"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6608-1307","authenticated-orcid":true,"given":"Xinyi","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harran","family":"Mkocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte A.","family":"Gaydos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Dize","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila K.","family":"West","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,7,13]]},"reference":[{"key":"pntd.0010629.ref001","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/S0140-6736(13)62182-0","article-title":"Trachoma","volume":"384","author":"HR Taylor","year":"2014","journal-title":"Lancet"},{"key":"pntd.0010629.ref002","volume-title":"Task Force for Global Health","author":"World Health Organization","year":"2015"},{"key":"pntd.0010629.ref003","doi-asserted-by":"crossref","first-page":"14","DOI":"10.12688\/wellcomeopenres.13423.2","article-title":"Clinical signs of trachoma are prevalent among Solomon Islanders who have no persistent markers of prior infection with Chlamydia trachomatis","volume":"3","author":"R Butcher","year":"2018","journal-title":"Wellcome Open Res"},{"issue":"21","key":"pntd.0010629.ref004","first-page":"00177","article-title":"Utility of photography for trachoma surveys: A systematic review","volume":"S0039-6257","author":"F Naufal","year":"2021","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"pntd.0010629.ref005","doi-asserted-by":"crossref","first-page":"e0004352","DOI":"10.1371\/journal.pntd.0004352","article-title":"Can We Use Antibodies to Chlamydia trachomatis as a Surveillance Tool for National Trachoma Control Programs? Results from a District Survey","volume":"10","author":"SK West","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"9467","key":"pntd.0010629.ref006","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(05)61029-X","article-title":"Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study","volume":"365","author":"MJ Burton","year":"2005","journal-title":"Lancet"},{"key":"pntd.0010629.ref007","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/1471-2334-14-216","article-title":"Longitudinal analysis of antibody responses to trachoma antigens before and after mass drug administration","volume":"14","author":"EB Goodhew","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"9","key":"pntd.0010629.ref008","doi-asserted-by":"crossref","first-page":"e0005863","DOI":"10.1371\/journal.pntd.0005863","article-title":"Prevalence of signs of trachoma, ocular Chlamydia trachomatis infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati","volume":"11","author":"A Cama","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"pntd.0010629.ref009","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/jamaophthalmol.2017.3062","article-title":"Surveillance Surveys for Reemergent Trachoma in Formerly Endemic Districts in Nepal From 2 to 10 Years After Mass Drug Administration Cessation","volume":"135","author":"SK West","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"pntd.0010629.ref010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4269\/ajtmh.20-0777","article-title":"Population-Based Prevalence of Chlamydia trachomatis Infection and Antibodies in Four Districts with Varying Levels of Trachoma Endemicity in Amhara, Ethiopia","volume":"104","author":"SD Nash","year":"2021","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"pntd.0010629.ref011","doi-asserted-by":"crossref","first-page":"e0009343","DOI":"10.1371\/journal.pntd.0009343","article-title":"Serology, infection, and clinical trachoma as tools in prevalence surveys for re-emergence of trachoma in a formerly hyperendemic district","volume":"15","author":"M Odonkor","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0010629.ref012","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1038\/s41598-018-21127-0","article-title":"Longitudinal change in the serology of antibodies to Chlamydia trachomatis pgp3 in children residing in a trachoma area","volume":"8","author":"SK West","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"pntd.0010629.ref013","doi-asserted-by":"crossref","first-page":"15225","DOI":"10.1038\/s41598-020-71833-x","article-title":"The effect of Mass Drug Administration for trachoma on antibodies to Chlamydia trachomatis pgp3 in children","volume":"10","author":"SK West","year":"2020","journal-title":"Sci Rep"},{"issue":"6","key":"pntd.0010629.ref014","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/09286586.2016.1238947","article-title":"Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation (ASANTE) Trial: Design and Baseline Characteristics","volume":"23","author":"AM Ervin","year":"2016","journal-title":"Ophthalmic Epidemiol"},{"issue":"4","key":"pntd.0010629.ref015","first-page":"477","article-title":"A simple system for the assessment of trachoma and its complications","volume":"65","author":"B Thylefors","year":"1987","journal-title":"Bull World Health Organ"},{"issue":"4","key":"pntd.0010629.ref016","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.diagmicrobio.2013.08.005","article-title":"Pooling ocular swab specimens from Tanzania for testing by Roche Amplicor and Aptima Combo 2 assays for the detection of Chlamydia trachomatis: accuracy and cost-savings","volume":"77","author":"L Dize","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"11","key":"pntd.0010629.ref017","doi-asserted-by":"crossref","first-page":"e1873","DOI":"10.1371\/journal.pntd.0001873","article-title":"CT694 and pgp3 as serological tools for monitoring trachoma programs","volume":"6","author":"EB Goodhew","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0010629.ref018","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1038\/s41467-018-07852-0","article-title":"The utility of serology for elimination surveillance of trachoma","volume":"9","author":"A Pinsent","year":"2018","journal-title":"Nat Commun"},{"issue":"9","key":"pntd.0010629.ref019","doi-asserted-by":"crossref","first-page":"e0008316","DOI":"10.1371\/journal.pntd.0008316","article-title":"The use of serology for trachoma surveillance: Current status and priorities for future investigation","volume":"14","author":"DL Martin","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0010629.ref020","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.3389\/fimmu.2019.01787","article-title":"Remembrance of Things Past: Long-Term B Cell Memory After Infection and Vaccination","volume":"10","author":"AE Palm","year":"2019","journal-title":"Front Immunol"},{"issue":"11","key":"pntd.0010629.ref021","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2010.06.004","article-title":"Kinetics of maternal antibodies against rubella and varicella in infants","volume":"29","author":"E Leuridan","year":"2011","journal-title":"Vaccine"},{"issue":"3","key":"pntd.0010629.ref022","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/oxfordjournals.aje.a116683","article-title":"Exposure to children and risk of active trachoma in Tanzanian women","volume":"137","author":"N Congdon","year":"1993","journal-title":"Am J Epidemiol"},{"issue":"10","key":"pntd.0010629.ref023","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"SL Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"pntd.0010629.ref024","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/(SICI)1097-0320(19960315)26:1<8::AID-CYTO2>3.0.CO;2-E","article-title":"Age- and sex-related changes in lymphocyte subpopulations of healthy Asian subjects: from birth to adulthood","volume":"26","author":"BW Lee","year":"1996","journal-title":"Cytometry"},{"issue":"1","key":"pntd.0010629.ref025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-3476(97)70313-5","article-title":"T-lymphocyte subsets in West African children: impact of age, sex, and season","volume":"130","author":"IM Lisse","year":"1997","journal-title":"J Pediatr"},{"issue":"1","key":"pntd.0010629.ref026","first-page":"23","article-title":"Levels of serum immunoglobulins in apparently healthy children and adults in Port Harcourt","volume":"28","author":"C Obiandu","year":"2013","journal-title":"Nigeria. Niger J Physiol Sci"},{"key":"pntd.0010629.ref027","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.mimet.2018.02.017","article-title":"Evaluation of the reproducibility of a serological test for antibodies to Chlamydia trachomatis pgp3: A potential surveillance tool for trachoma programs","volume":"147","author":"H Kaur","year":"2018","journal-title":"J Microbiol Methods"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0010629","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T00:00:00Z","timestamp":1658707200000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0010629","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T13:42:29Z","timestamp":1658756549000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0010629"}},"subtitle":[],"editor":[{"given":"Prashant","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,7,13]]},"references-count":27,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0010629","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,13]]}}}